高危患者(包括绝经妇女、50岁以上中老年男性、低创伤性骨折既往史)以及吸收障碍患者应接受骨密度检查,以获得基线资料。[95]Duggan SN, Smyth ND, Murphy A, et al. High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Feb;12(2):219-28.http://www.ncbi.nlm.nih.gov/pubmed/23856359?tool=bestpractice.com 如果发现骨量减少,应在 2 年内进行监测检查。对于骨质疏松症患者,应开始适当的药物治疗和/或咨询骨科医师。[95]Duggan SN, Smyth ND, Murphy A, et al. High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014 Feb;12(2):219-28.http://www.ncbi.nlm.nih.gov/pubmed/23856359?tool=bestpractice.com